The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2017 | ESMO guidelines for thymic cancer management
Nicolas Girard, MD, from the University Hospital of Lyon, Lyon, France discusses his presentation of the ESMO clinical practice guidelines for the management of thymic cancer, presented at the annual meeting of the European Lung Cancer Conference (ELCC) 2017, Geneva, Switzerland. Thymic cancer is a rare malignancy which requires a multidisciplinary approach in its management. Prof. Girard outlines the various treatment options available for thymic tumors, highlighting the importance of clinical guidelines.
